A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
SBC Medical Group Holdings Inc
SBC
$297M
Mkt Cap
$3.06
+4.44%
SBC Medical Group Holdings Inc (SBC) has a current P/E ratio of 7.3, compared to its historical median P/E of 12.1. The stock is currently considered Cheap based on its historical valuation range.
SBC Medical Group Holdings Inc (SBC) has a 5-year average return on invested capital (ROIC) of 76.5%. This indicates strong capital allocation and a potential competitive advantage.
SBC Medical Group Holdings Inc (SBC) has a market capitalization of $314M. It is classified as a small-cap stock.
SBC Medical Group Holdings Inc (SBC) does not currently pay a regular dividend.
Based on historical P/E analysis, SBC Medical Group Holdings Inc (SBC) appears cheap. The current P/E of 7.3 is 40% below its historical median of 12.1. The estimated fair value CAGR (P/E method) is 0.9%.
SBC Medical Group Holdings Inc (SBC) operates in the Services-Offices & Clinics Of Doctors Of Medicine industry, within the Healthcare sector.
SBC Medical Group Holdings Inc (SBC) reported annual revenue of $205 million in its most recent fiscal year, based on SEC EDGAR filings.
Unless the context indicates otherwise, any references herein to the “Company”, “we”, “us” and “our” refer to (i) SBC Medical Group, Inc. (formerly known as SBC Medical Group Holdings Incorporated), a Delaware corporation (“Legacy SBC”), and its consolidated subsidiaries and variable interest entity (“VIE”), prior to the consummation of Business Combination and to (ii) SBC Medical Group Holdings Incorporated, the Combined Entity and its consolidated subsidiaries and VIE following the Business Combination, and reference herein to “Pono” refers to predecessor company prior to the consummation of the Business Combination. We were originally incorporated in Delaware on February 12, 2021 under the name “Pono Capital Two, Inc.,” referred to herein as “Pono,” as a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
| Metric | TTM | FY2024 |
|---|---|---|
| Revenue | 178M | 205M |
| Net Income | 43M | 47M |
| EPS | $0.42 | $0.48 |
| Free Cash Flow | -36M | 18M |
| ROIC | 30.7% | 76.5% |
| Gross Margin | 74.1% | 76.0% |
| Debt/Equity | 0.00 | 0.03 |
| Dividends/Share | $0.00 | - |
| Operating Income | 59M | 70M |
| Operating Margin | 33.3% | 34.2% |
| ROE | 17.5% | 27.6% |
| Shares Outstanding | 103M | 97M |
| Metric | ||
|---|---|---|
| Income Statement | ||
| Revenue | 205M | 178M |
| Gross Margin | 76.0% | 74.1% |
| R&D | N/A | N/A |
| SG&A | N/A | N/A |
| EBIT | 70M | 59M |
| Op. Margin | 34.2% | 33.3% |
| Net Income | 47M | 43M |
| Net Margin | 22.7% | 24.3% |
| Non-Recurring | 15M | 15M |
| Returns on Capital | ||
| ROIC | 76.5% | 30.7% |
| ROE | 27.6% | 17.5% |
| ROA | 17.8% | 13.5% |
| Cash Flow | ||
| Op. Cash Flow | 21M | -35M |
| Free Cash Flow | 18M | -36M |
| Owner Earnings | 3.8M | -51M |
| CapEx | 2.6M | 1.2M |
| Maint. CapEx | 3.8M | 3.8M |
| Growth CapEx | 0 | 0 |
| D&A | 3.8M | 3.8M |
| CapEx/OCF | 12.5% | 0.0% |
| Capital Allocation | ||
| Dividends Paid | 0 | 0 |
| Dividend Yield | N/A | N/A |
| Share Buybacks | 0 | 0 |
| Buyback Yield | N/A | 0.0% |
| Stock-Based Comp | 13M | 13M |
| Debt Repayment | 0 | 0 |
| Balance Sheet | ||
| Net Debt | -119M | -127M |
| Cash & Equiv. | N/A | 127M |
| Long-Term Debt | 6.5M | 6.5M |
| Debt/Equity | 0.03 | 0.00 |
| Interest Coverage | 2484.2 | 2484.2 |
| Equity | 195M | 248M |
| Total Assets | 266M | 321M |
| Total Liabilities | 71M | 73M |
| Intangibles | 6.2M | 6.2M |
| Retained Earnings | 189M | 189M |
| Working Capital | 123M | 123M |
| Current Assets | 184M | 184M |
| Current Liabilities | 61M | 61M |
| Per Share Data | ||
| EPS | 0.48 | 0.42 |
| Owner EPS | 0.04 | -0.50 |
| Book Value | 2.01 | 2.42 |
| Cash Flow/Share | 0.21 | 0.46 |
| Dividends/Share | N/A | 0.00 |
| Shares Out. | 97.1M | 102.6M |
| Valuation | ||
| P/E Ratio | 12.1 | 7.3 |
| P/FCF | 31.3 | N/A |
| EV/EBIT | 6.3 | 3.1 |
| Price/Book | 2.9 | 1.3 |
| Price/Sales | 5.1 | 1.8 |
| FCF Yield | 3.2% | -11.4% |
| Market Cap | 563M | 314M |
| Avg. Price | 10.89 | 3.06 |
| Year-End Price | 5.80 | 3.06 |
SBC Medical Group Holdings Inc passes 5 of 9 quality checks, suggesting mixed fundamentals.
SBC Medical Group Holdings Inc trades at 7.3x trailing earnings, compared to its 15-year median P/E of 12.1x, suggesting it is currently Cheap relative to its historical range. The company's 5-year average ROIC is 76.5% with a gross margin of 76.0%. At current prices, the estimated annualized return to fair value is -3.4%.
SBC Medical Group Holdings Inc (SBC) has a net profit margin of 22.7%. This is a strong margin indicating high profitability.
SBC Medical Group Holdings Inc (SBC) generated $18 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
SBC Medical Group Holdings Inc (SBC) has a debt-to-equity ratio of 0.03. This indicates a conservatively financed balance sheet.
SBC Medical Group Holdings Inc (SBC) reported earnings per share (EPS) of $0.48 in its most recent fiscal year.
SBC Medical Group Holdings Inc (SBC) has a return on equity (ROE) of 27.6%. This indicates the company generates strong returns for shareholders.
SBC Medical Group Holdings Inc (SBC) has a 5-year average gross margin of 76.0%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 1 years of financial data for SBC Medical Group Holdings Inc (SBC), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
SBC Medical Group Holdings Inc (SBC) has a book value per share of $2.01, based on its most recent annual SEC filing.